Plea for an In-Depth Analysis of the RESHAPE-HF2 Results.

Competing Interests: Funding Support and Author Disclosures Dr Obadia has served on the Scientific Advisory Board or received grants from Abbott, Carmat, Edwards, Jenscare, andTricare; and has served as a consultant for Delacroix-Chevalier and Landanger. Dr Armoiry has provided scientific advice to W.L. Gore with honoraria delivered to an academic association. Dr Messika-Zeitoun has received research grant from Edwards Lifesciences; and is a consultant for PrediSurge. Dr Trochu has served as a Scientific Advisory Board member and/or received honoraria/grants from Abbott, AstraZeneca, Bristol Myers Squibb, Vifor-Pharma, Bayer, Novartis, and Boehringer Ingelheim. Dr Iung has reported that he has no relationships relevant to the contents of this paper to disclose.